Cargando…

Analysis and identification of drug similarity through drug side effects and indications data

BACKGROUND: The measurement of drug similarity has many potential applications for assessing drug therapy similarity, patient similarity, and the success of treatment modalities. To date, a family of computational methods has been employed to predict drug-drug similarity. Here, we announce a computa...

Descripción completa

Detalles Bibliográficos
Autores principales: Torab-Miandoab, Amir, Poursheikh Asghari, Mehdi, Hashemzadeh, Nastaran, Ferdousi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926629/
https://www.ncbi.nlm.nih.gov/pubmed/36788528
http://dx.doi.org/10.1186/s12911-023-02133-3
_version_ 1784888319420661760
author Torab-Miandoab, Amir
Poursheikh Asghari, Mehdi
Hashemzadeh, Nastaran
Ferdousi, Reza
author_facet Torab-Miandoab, Amir
Poursheikh Asghari, Mehdi
Hashemzadeh, Nastaran
Ferdousi, Reza
author_sort Torab-Miandoab, Amir
collection PubMed
description BACKGROUND: The measurement of drug similarity has many potential applications for assessing drug therapy similarity, patient similarity, and the success of treatment modalities. To date, a family of computational methods has been employed to predict drug-drug similarity. Here, we announce a computational method for measuring drug-drug similarity based on drug indications and side effects. METHODS: The model was applied for 2997 drugs in the side effects category and 1437 drugs in the indications category. The corresponding binary vectors were built to determine the Drug-drug similarity for each drug. Various similarity measures were conducted to discover drug-drug similarity. RESULTS: Among the examined similarity methods, the Jaccard similarity measure was the best in overall performance results. In total, 5,521,272 potential drug pair's similarities were studied in this research. The offered model was able to predict 3,948,378 potential similarities. CONCLUSION: Based on these results, we propose the current method as a robust, simple, and quick approach to identifying drug similarity.
format Online
Article
Text
id pubmed-9926629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99266292023-02-15 Analysis and identification of drug similarity through drug side effects and indications data Torab-Miandoab, Amir Poursheikh Asghari, Mehdi Hashemzadeh, Nastaran Ferdousi, Reza BMC Med Inform Decis Mak Research BACKGROUND: The measurement of drug similarity has many potential applications for assessing drug therapy similarity, patient similarity, and the success of treatment modalities. To date, a family of computational methods has been employed to predict drug-drug similarity. Here, we announce a computational method for measuring drug-drug similarity based on drug indications and side effects. METHODS: The model was applied for 2997 drugs in the side effects category and 1437 drugs in the indications category. The corresponding binary vectors were built to determine the Drug-drug similarity for each drug. Various similarity measures were conducted to discover drug-drug similarity. RESULTS: Among the examined similarity methods, the Jaccard similarity measure was the best in overall performance results. In total, 5,521,272 potential drug pair's similarities were studied in this research. The offered model was able to predict 3,948,378 potential similarities. CONCLUSION: Based on these results, we propose the current method as a robust, simple, and quick approach to identifying drug similarity. BioMed Central 2023-02-14 /pmc/articles/PMC9926629/ /pubmed/36788528 http://dx.doi.org/10.1186/s12911-023-02133-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Torab-Miandoab, Amir
Poursheikh Asghari, Mehdi
Hashemzadeh, Nastaran
Ferdousi, Reza
Analysis and identification of drug similarity through drug side effects and indications data
title Analysis and identification of drug similarity through drug side effects and indications data
title_full Analysis and identification of drug similarity through drug side effects and indications data
title_fullStr Analysis and identification of drug similarity through drug side effects and indications data
title_full_unstemmed Analysis and identification of drug similarity through drug side effects and indications data
title_short Analysis and identification of drug similarity through drug side effects and indications data
title_sort analysis and identification of drug similarity through drug side effects and indications data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926629/
https://www.ncbi.nlm.nih.gov/pubmed/36788528
http://dx.doi.org/10.1186/s12911-023-02133-3
work_keys_str_mv AT torabmiandoabamir analysisandidentificationofdrugsimilaritythroughdrugsideeffectsandindicationsdata
AT poursheikhasgharimehdi analysisandidentificationofdrugsimilaritythroughdrugsideeffectsandindicationsdata
AT hashemzadehnastaran analysisandidentificationofdrugsimilaritythroughdrugsideeffectsandindicationsdata
AT ferdousireza analysisandidentificationofdrugsimilaritythroughdrugsideeffectsandindicationsdata